FDA Adverse Event Injury Summary report: N

DURAGEN PLUS DURAL REGENERATION MATRIX 2X2 1 PA

MDR report key: 3137051 · Received May 28, 2013

Report

Report Number
1121308-2013-00015
Event Type
Injury
Date Received
May 28, 2013
Date of Event
March 31, 2013
Report Date
May 28, 2013
Manufacturer
INTEGRA LIFESCIENCES CORP.
Product Code
GXQ
PMA / PMN Number
K032693
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE INVOLVED IN THE REPORTED INCIDENT IS NOT EXPECTED TO BE RECEIVED FOR EVALUATION. AN INVESTIGATION HAS BEEN INITIATED BASED UPON THE REPORTED INFORMATION.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE REGISTERED NURSE (RN) COMPLETED A CHART REVIEW ON THE DURAGEN AND FOUND THAT THIS PATIENT HAD A FEVER IN THE IMMEDIATE POSTOPERATIVE PERIOD USING THEIR HOSPITAL CRITERIA. ADDITIONAL INFORMATION WAS REQUESTED AND ON (B)(4) 2013, THE FOLLOWING INFORMATION WAS RECEIVED: ONE QUANTITY OF DURAGEN (PRODUCT ID (B)(4) WITH LOT NUMBER 1125526) WAS IMPLANTED IN THE PATIENT ON (B)(6) 2013 DURING A LUMBAR SPINAL FUSION. THE FEVER CRITERIA USED BY THE USER FACILITY WAS REPORTED AS A TEMPERATURE OF 100.4 DEGREES FAHRENHEIT OR GREATER. THE PATIENT'S TEMPERATURE READINGS WERE ON: (B)(6) 2013 = 101.1 F, ON (B)(6) 2013 = 101.1 F, ON (B)(6) 2013 = 100.3 F, ON (B)(6) 2013 = 100.1 F, ON (B)(6) 2013 = 101.0 F, AND ON (B)(6) 2013 = NO FEVER. THE PATIENT DID NOT HAVE ANY FEVER PRIOR TO THE SURGERY AND/OR IMPLANTATION OF THE DURAGEN. NO CULTURES WERE TAKEN. NO SPECIFIC TREATMENT WAS GIVEN TO THE PATIENT FOR THE FEVER. HOWEVER, AS PER PROTOCOL FOR THE SURGERY, THE PATIENT WAS GIVEN ANTIBIOTICS AFTER THE SURGERY. THE PATIENT WAS ALSO GIVEN TYLENOL FOR PAIN. PATIENT OUTCOME WAS REPORTED AS GOOD AND THE PATIENT WAS DISCHARGED FROM THE HOSPITAL ON 03/07/2013 WITHOUT ANY FEVER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
233536 DURAGEN PLUS DURAL REGENERATION MATRIX 2X2 1 PA NA GXQ INTEGRA LIFESCIENCES CORP. 1125526

Patients

Seq Age Sex Outcome Treatment
1 46 YR Other